本页面由Tiger Trade Technology Pte. Ltd.提供服务

eFFECTOR Therapeutics, Inc.

0.0002
0.0000
成交量:404.00
成交额:0.08
市值:940.88
市盈率:0.00
高:0.0002
开:0.0002
低:0.0002
收:0.0002
52周最高:0.0200
52周最低:0.0000
股本:470.44万
流通股本:458.21万
量比:1.21
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-12.4244
每股收益(LYR):-16.3748
净资产收益率:-946.56%
总资产收益率:-83.33%
市净率:0.00
市盈率(LYR):0.00

数据加载中...

2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/01/31

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/01/24

重要事件披露

8-K - Current report
2021/11/08

重要事件披露

8-K - Current report
2021/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/01

重要事件披露

8-K - Current report
2021/10/01

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/23

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/09/13

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/07

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/31

重要事件披露

8-K - Current report
2021/08/31

重要事件披露

8-K/A [Amend] - Current report
2021/08/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/25

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/08/24

重要事件披露

8-K - Current report